CIK 0001861107 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Ceribell, Inc.
Sign in to watch- Ticker
- CBLL
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 471785452
- Phone
- (800) 436-0826
- Business address
- 360 N. PASTORIA AVENUE, SUNNYVALE, CA, 94085
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,415,987
- in 16 filings, $3.9M under 10b5-1 plans
Net −$4,415,987. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Chao Xingjuan −$2.5M President and CEO sold 12% of stake
- Blumberg Scott −$938K Chief Financial Officer sold 20% of stake
- Woo Raymond −$417K Chief Technology Officer sold 8% of stake
- Taylor Joseph Michael −$278K Director sold 21% of stake
- Foehr David −$269K Senior VP, Finance and PAO sold 25% of stake
Reading 16 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-01 | Woo Raymond Chief Technology Officer | Option exercise 10b5-1 | +1,469 | $2.24 | $3K | 199,117 |
| 2026-05-01 | Woo Raymond Chief Technology Officer | Sale 10b5-1 | −1,469 | $20.39 | $30K | 197,648 |
| 2026-05-01 | Woo Raymond Chief Technology Officer | Option exercise 10b5-1 | +3,024 | $4.70 | $14K | 200,672 |
| 2026-05-01 | Woo Raymond Chief Technology Officer | Sale 10b5-1 | −3,024 | $20.43 | $62K | 197,648 |
| 2026-05-01 | Woo Raymond Chief Technology Officer | Option exercise 10b5-1 | +6,611 | $4.70 | $31K | 204,259 |
| 2026-05-01 | Woo Raymond Chief Technology Officer | Sale 10b5-1 | −6,611 | $20.45 | $135K | 197,648 |
| 2026-05-01 | Woo Raymond Chief Technology Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,469 | 8,389 | ||
| 2026-05-01 | Woo Raymond Chief Technology Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −3,024 | 32,697 | ||
| 2026-05-01 | Woo Raymond Chief Technology Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −6,611 | 19,067 | ||
| 2026-04-06 | Chao Xingjuan President and CEO | Sale 10b5-1 | −14,000 | $18.40 | $258K | 850,347 |
| 2026-04-06 | Chao Xingjuan President and CEO | Option exercise 10b5-1 | +1,446 | $4.70 | $7K | 851,793 |
| 2026-04-06 | Chao Xingjuan President and CEO | Sale 10b5-1 | −1,446 | $18.40 | $27K | 850,347 |
| 2026-04-06 | Chao Xingjuan President and CEO | Option exercise 10b5-1 | +23,554 | $4.70 | $111K | 873,901 |
| 2026-04-06 | Chao Xingjuan President and CEO | Sale 10b5-1 | −23,554 | $18.40 | $433K | 850,347 |
| 2026-04-06 | Chao Xingjuan President and CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,446 | 293,048 | ||
| 2026-04-06 | Chao Xingjuan President and CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −23,554 | 148,585 | ||
| 2026-04-01 | Chao Xingjuan President and CEO | Grant or award | +97,555 | 864,347 | ||
| 2026-04-01 | Chao Xingjuan President and CEO | Grant or award · Stock Option (Right to Buy) | +162,592 | 162,592 | ||
| 2026-04-01 | Blumberg Scott Chief Financial Officer | Grant or award | +30,736 | 149,070 | ||
| 2026-04-01 | Blumberg Scott Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +51,227 | 51,227 |
Page 6 of 17 · 330 trades